about
Structure of a conserved dimerization domain within the F-box protein Fbxo7 and the PI31 proteasome inhibitorRegulation of the E stress response by DegS: how the PDZ domain keeps the protease inactive in the resting state and allows integration of different OMP-derived stress signals upon folding stressStructural adaptation of the plant protease Deg1 to repair photosystem II during light exposureTargeted therapies: Should we be aghast at the AVAGAST data?Therapy: Conscious uncoupling.Genetics: The COGS are turning in breast, ovarian and prostate cancer.Radiotherapy: Sparing early stage patients with Hodgkin lymphoma.Targeted therapies: the maths behind combination therapy.Genetics: Causative genes identified in rare renal ciliopathies.Renal fibrosis: KIM-1 expression links kidney injury with CKD in mice.From ASCO-gynaecological cancer: Advances in cervical cancer screening and treatment.Transplantation: socioeconomic factors most important.Chronic kidney disease: after nephron reduction, podoctyes get in on the AKT.Diabetes: efficacy of dapagliflozin associated with renal function.Clinical trials: High-impact session from kidney week.Imaging: Red light warning sign for clear-cell renal cell carcinoma--REDECT reveals imaging biomarker.Targeted therapies: hope for pancreatic neuroendocrine tumors.Haematological cancer: new standard of care?Targeted therapies: model reveals addiction to oncogenes.Disease prevention: Pain killer--cancer preventer.Nephrotic syndrome: Negative feedback loop reveals novel potential therapy.Hypertension: Uromodulin identified as a potential therapeutic target.High drug attrition rates--where are we going wrong?Oncology trials--the elephant in the roomSurgical oncology: Cancer risk reduction in BRCA mutation carriersTargeted therapies: New standard of therapy for HER2-positive gastric cancers?Radiotherapy: stop recurring breast cancer nightmaresImmunotherapy: a first for first-line therapy in NSCLCGastrointestinal cancer: a new dawn for CT scans in colon screening?Diagnostic imaging: A new dawn for CT scans in colon screening?Patient profiling in breast cancer--is knowledge power?Genetics: In colorectal cancer, not all KRAS mutations are created equalGastrointestinal cancer: Combine and conquerUrological cancer: Cause and effect in prostate cancerGynecological cancer: DOvE pilots its way to intriguing resultsHematological cancer: a new option for patients with PTCLSurgery: Delays may improve outcomesLung cancer: Maintenance chemotherapy--a stitch in time saves nine?Breast cancer: Resource poor but ingenuity richGenetics: Personalized medicine and tumour heterogeneity
P50
Q24315043-18959794-26C9-418A-8345-B1A3B9FDCC00Q27648793-986D83F5-0580-4285-9AF3-EF59718DE8EAQ27667631-AF5C8CD8-B801-4BEA-BDBA-B8208EAA2AF7Q34011654-5F653E55-40FB-4BEA-8916-C1B48AEC005FQ35768816-9979D497-0069-4BF3-AF40-47D7C87ADAC9Q43549804-F8E3792B-F30F-4D8B-BE9A-0447EAEA88F1Q43614596-DF71119A-97AC-4086-8ED9-E782E32A389AQ44616212-D8A0EA08-AE41-4970-82ED-BF8FBA17F487Q45015758-FE6BB9E4-5F81-4944-B0DA-DB36295A6571Q45246300-F28EE7F2-46A0-4251-AE9E-678AC2C80249Q45791069-ACE3A3D5-4189-4D14-AF0A-0E151892C8A1Q45996232-293CB1E4-81C6-4452-A570-A9D9691536A7Q46168788-F828FFF9-0C46-40C4-B766-4B2C8C7F259DQ46353923-833C3CF6-F466-47DC-B037-AFA7778C92E6Q46569181-5FA3AD77-F771-4A1B-A65B-BD4E7262D0C1Q46667293-B06D4312-F259-41B4-9277-2A02794EA0BAQ47589943-B50E0360-FA8D-4AFE-852C-498EF132E1F1Q51051242-3CF0E10A-B72B-42C6-8DFA-8B2A925AAE09Q52299631-6C2361E6-5BD6-486A-93D6-345A5480CF73Q53900579-3AE2BC92-CA49-4178-B733-BF474305AD3DQ54432272-214C927D-ED0E-4BC9-A1C7-83CF8DDE65A5Q54577782-19875DA7-8E19-4C6A-B172-BE70BA6E6DB1Q55054118-8EF49C5D-305D-4735-BE1E-DF42F439035BQ57866601-B1050779-8C55-4756-A284-6DC020C75418Q82303484-BF935FBE-3D0B-4E71-9D24-EAA703AA7E0CQ82303498-ED2AAFF1-6398-434B-98C8-082A3D70E59EQ82316328-194C7304-BED0-46B1-84BF-682C37400ED9Q82413953-12F9ADA1-24DD-43DB-A2A6-2A0A475810BBQ82715265-6713C2F0-9A1E-4233-B13E-4C2A94383B78Q82895177-9DD66B62-55F9-40E0-9BC1-800348FB8DFCQ83080578-CF90EE96-389F-4FEA-B5C4-45653C73B4B7Q83157243-14035695-8137-4613-A472-C897E983C1B7Q83254693-EA3208EF-A0D0-49C7-9D78-FBDBE480E7C5Q83310085-54AD3560-3C12-415C-9CE1-262F0A3815B4Q83396435-2B71BC4D-BEE0-4EE1-96A2-7F42E0BCEAD5Q83473291-835879E7-E44C-4E83-A8FE-3DA102D3CECAQ83500810-2E018782-C46F-40BD-8F68-A4A2DBB0328BQ83576613-FA62E70A-1BBA-45E9-925C-342F4F6E0337Q83630198-BD2CE2AF-85F3-4CFA-A12F-1810DF9FF96BQ83696873-8FE29F56-E010-4F72-94A0-919661C6F328
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Rebecca Kirk
@ast
Rebecca Kirk
@en
Rebecca Kirk
@es
Rebecca Kirk
@nl
Rebecca Kirk
@sl
ريبيكا كيرك
@ar
type
label
Rebecca Kirk
@ast
Rebecca Kirk
@en
Rebecca Kirk
@es
Rebecca Kirk
@nl
Rebecca Kirk
@sl
ريبيكا كيرك
@ar
prefLabel
Rebecca Kirk
@ast
Rebecca Kirk
@en
Rebecca Kirk
@es
Rebecca Kirk
@nl
Rebecca Kirk
@sl
ريبيكا كيرك
@ar
P106
P1153
36134612900
55851422000
P21
P31
P496
0000-0003-3541-0168